Dechra Pharmaceuticals plc Company Profile (LON:DPH)

About Dechra Pharmaceuticals plc

Dechra Pharmaceuticals plc logoDechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Genera and Dechra Pharmaceuticals Manufacturing. It manufactures and markets Companion Animal, Equine and Food producing Animal Products. It includes third party manufacturing and other non-core activities sales. The NA Pharmaceuticals Segment consists of Dechra Veterinary Products US, Putney, Dechra Veterinary Products Canada, and Dechra-Brovel that sell Companion Animal and Equine Products into those territories. The Pharmaceuticals Research and Development Segment includes its pharmaceutical research and development activities. Its offerings include Osphos and Vetoryl.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: DPH
  • CUSIP:
Key Metrics:
  • Previous Close: $19.16
  • 50 Day Moving Average: $1469.38
  • 200 Day Moving Average: $1367.23
  • 52-Week Range: GBX 811 - GBX 1,582
  • Trailing P/E Ratio: 109.22
  • P/E Growth: 1.59
  • Market Cap: $1.43B
  • Outstanding Shares: 92,744,000
Additional Links:

Analyst Ratings

Consensus Ratings for Dechra Pharmaceuticals plc (LON:DPH) (?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 1,337.43

Analysts' Ratings History for Dechra Pharmaceuticals plc (LON:DPH)
Show:
DateFirmActionRatingPrice TargetDetails
2/24/2017FinnCapReiterated RatingUnder ReviewView Rating Details
1/26/2017Panmure GordonReiterated RatingUnder ReviewView Rating Details
1/17/2017Numis Securities LtdReiterated RatingAddGBX 1,520View Rating Details
12/15/2016Jefferies Group LLCBoost Price TargetHoldGBX 1,295 -> GBX 1,320View Rating Details
10/21/2016N+1 SingerBoost Price TargetBuyGBX 1,350 -> GBX 1,412View Rating Details
10/21/2016Stifel NicolausReiterated RatingHoldGBX 1,250View Rating Details
9/5/2016InvestecBoost Price TargetBuyGBX 1,300 -> GBX 1,400View Rating Details
3/17/2016Royal Bank of CanadaUpgradeOutperformGBX 1,080 -> GBX 1,320View Rating Details
9/7/2015Shore CapitalReiterated RatingBuyView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Dechra Pharmaceuticals plc (LON:DPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017N/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dechra Pharmaceuticals plc (LON:DPH)
Current Year EPS Consensus Estimate: $56.74 EPS

Dividends

Dividend History for Dechra Pharmaceuticals plc (LON:DPH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/5/2016GBX 12.910.92%10/27/201610/27/201611/18/2016
2/22/2016GBX 5.550.47%3/10/20163/10/20164/6/2016
9/7/2015GBX 11.821.26%10/29/201510/29/201511/20/2015
9/8/2014GBX 10.651.4%11/6/201411/6/201411/21/2014
2/25/2014GBX 4.750.68%3/12/20143/12/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dechra Pharmaceuticals plc (LON:DPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/30/2016Tony GriffinInsiderSell17,133GBX 1,292£221,358.36
6/3/2016Rice,TonyInsiderBuy20,000GBX 1,141£228,200
3/21/2016Nesmes,Anne-FrancoiseInsiderSell3,100GBX 1,208£37,448
9/9/2015Nesmes,Anne-FrancoiseÂInsiderSell18,319GBX 940£172,198.60
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dechra Pharmaceuticals plc (LON:DPH)
DateHeadline
marketexclusive.com logoAnalyst Activity – FinnCap Reiterates Under Review on Dechra ... - Market Exclusive (LON:DPH)
marketexclusive.com - February 24 at 11:49 AM
News IconTicker Scope: Tracking Shares of Dechra Pharmaceuticals plc (LSE:DPH) - Benton Bulletin (LON:DPH)
bentonbulletin.com - February 23 at 9:50 PM
News IconDechra Pharmaceuticals (LON:DPH) Analyst Target Prices - UK Market News (LON:DPH)
www.ukmarketnews.co.uk - February 23 at 3:05 AM
News IconAnalysts Consensus For Dechra Pharmaceuticals (LON:DPH) - NewsDen (LON:DPH)
newsden.net - February 22 at 6:30 AM
News IconLooking at the Numbers for Dechra Pharmaceuticals plc (LSE:DPH) - Baldwin Journal (LON:DPH)
baldwinjournal.com - February 22 at 6:30 AM
News IconOutstanding Analyst Ratings For Dechra Pharmaceuticals (LON:DPH) - UK Market News (LON:DPH)
www.ukmarketnews.co.uk - February 18 at 4:32 PM
News IconDrilling Down into the Technicals on Dechra Pharmaceuticals plc (LSE:DPH) - Midway Monitor (LON:DPH)
midwaymonitor.com - February 16 at 2:55 PM
uk.finance.yahoo.com logoWhy I’m avoiding these exciting growth shares right now (LON:DPH)
uk.finance.yahoo.com - February 16 at 2:55 PM
News IconStock Concentration on Shares of Dechra Pharmaceuticals PLC (DPH.L) - Sherwood Daily (LON:DPH)
sherwooddaily.com - February 6 at 4:50 PM
money.aol.co.uk logoShould you make room for Pets At Home Group plc after today's update? (LON:DPH)
money.aol.co.uk - January 20 at 4:08 AM
uk.finance.yahoo.com logoShould you make room for Pets At Home Group plc after today's update? - Yahoo Finance UK (LON:DPH)
uk.finance.yahoo.com - January 19 at 11:07 PM
uk.finance.yahoo.com logoShould you make room for Pets At Home Group plc after today’s update? (LON:DPH)
uk.finance.yahoo.com - January 19 at 6:06 PM
News IconRSI Update on Shares of Dechra Pharmaceuticals PLC (DPH.L) - Springdale Times (LON:DPH)
springdaletimes.com - January 18 at 5:09 PM
uk.finance.yahoo.com logoDoes this pharma's 56% sales growth make it a better buy than GlaxoSmithKline plc? - Yahoo Finance UK (LON:DPH)
uk.finance.yahoo.com - January 17 at 8:22 AM
finance.yahoo.com logoDechra® Pharmaceuticals PLC Trading Update (LON:DPH)
finance.yahoo.com - January 17 at 8:22 AM
uk.finance.yahoo.com logoDoes this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc? (LON:DPH)
uk.finance.yahoo.com - January 17 at 8:22 AM
News IconDechra Pharmaceuticals (LON:DPH) Recent Analyst Updates - NewsDen (LON:DPH)
newsden.net - January 13 at 5:32 PM
News IconStock Watch: FCF Score Check on Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 21 at 10:29 AM
News IconVolatility Watch on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 19 at 5:40 AM
marketexclusive.com logoAnalyst Activity – Jefferies Group Raises Its Price Target On Dechra Pharmaceuticals plc (LON:DPH) to GBX 1,320 (LON:DPH)
marketexclusive.com - December 15 at 5:21 PM
News IconShorts Action: Dechra Pharmaceuticals plc (DPH) Jumped 0.08% on Dec 12 - Herald KS (LON:DPH)
heraldks.com - December 12 at 5:02 PM
News IconStock Update: Focusing on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 9 at 7:01 AM
News IconMarket Check: Narrowing in on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 8 at 2:01 AM
News IconWhat The Charts Are Saying About Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 7 at 3:59 PM
News IconDirector Deals - Dechra Pharmaceuticals PLC (DPH) (LON:DPH)
www.youinvest.co.uk - December 5 at 11:59 AM
News IconLooking at the Numbers for Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 2 at 9:15 AM
News IconUpdate on Valuation Formula's For Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - December 1 at 5:38 AM
stockmarketwire.com logoDechra options exercised (LON:DPH)
www.stockmarketwire.com - November 30 at 8:17 AM
News IconInvestors are Watching Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 22 at 4:12 PM
News IconFree Cash Flow Score in Focus for Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 20 at 8:47 AM
News IconF-Score in Review on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 18 at 4:01 PM
News IconDechra Pharmaceuticals plc (LSE:DPH): Poised for Long-Term ... - Simply Wall St (LON:DPH)
simplywall.st - November 18 at 4:01 PM
News IconTrading Corner: Focusing in on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 17 at 7:31 AM
News IconStock Spotlight: Zooming in on Shares of Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 16 at 6:21 AM
News IconVC Score In Focus for Dechra Pharmaceuticals plc (LSE:DPH) - The Business Journal (LON:DPH)
belmontbusinessjournal.com - November 15 at 10:59 PM
News IconNew Study: Dechra Pharmaceuticals Plc (DPH) - Financial and Strategic SWOT Analysis Review (LON:DPH)
reports.pr-inside.com - November 15 at 5:00 PM
uk.finance.yahoo.com logoCould these top-performing stocks be about to collapse? (LON:DPH)
uk.finance.yahoo.com - November 7 at 5:46 AM
trustnet.com logoTop ranked fund manager joins award-winning fund (LON:DPH)
www.trustnet.com - November 1 at 8:55 AM
capitalcube.com logoDechra Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : DPH-GB : October 25, 2016 (LON:DPH)
www.capitalcube.com - October 25 at 9:33 AM
forbes.com logoAre These Pharma Fizzers 'Hot Buys' After Today's News? (LON:DPH)
www.forbes.com - October 21 at 4:44 PM
News IconRecent Broker Updates On Dechra Pharmaceuticals (LON:DPH) - NewsDen (LON:DPH)
newsden.net - October 21 at 7:09 AM
publicnow.com logoPre Annual General Meeting Statement (LON:DPH)
www.publicnow.com - October 21 at 7:09 AM
publicnow.com logoDechra complete acquisition in Australia (LON:DPH)
www.publicnow.com - October 14 at 7:20 AM
trustnet.com logoDechra Pharm PLC (DPH) (LON:DPH)
www.trustnet.com - September 30 at 9:43 AM
capitalcube.com logoDechra Pharmaceuticals Plc : Overvalued relative to peers, but may deserve another look (LON:DPH)
www.capitalcube.com - September 28 at 4:32 PM
directorstalkinterviews.com logoDechra Pharmaceuticals plc 12.5% Potential Upside Indicated by Cantor Fitzgerald - DirectorsTalk Interviews (LON:DPH)
www.directorstalkinterviews.com - September 27 at 9:16 AM
capitalcube.com logoDechra Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : DPH-GB : September 26, 2016 (LON:DPH)
www.capitalcube.com - September 26 at 9:24 AM
News IconNumis Securities Ltd Reiterates Hold Rating for Dechra Pharmaceuticals plc (DPH) - Petro Global News 24 (LON:DPH)
petroglobalnews24.com - September 23 at 4:27 PM
marketwired.com logoDechra Pharmaceuticals PLC: Australian Acquisition-Apex Laboratories for A$55m - Marketwired (press release) (LON:DPH)
www.marketwired.com - September 17 at 9:25 AM
investingnews.com logoDechra Pharmaceuticals to Acquire Apex Laboratories - Investing News Network (press release) (registration) (blog) (LON:DPH)
investingnews.com - September 16 at 4:34 PM

Social

What is Dechra Pharmaceuticals plc's stock symbol?

Dechra Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "DPH."

How often does Dechra Pharmaceuticals plc pay dividends? What is the dividend yield for Dechra Pharmaceuticals plc?

Dechra Pharmaceuticals plc announced a dividend on Monday, September 5th. Shareholders of record on Thursday, October 27th will be paid a dividend of GBX 12.91 per share on Friday, November 18th. This represents a yield of 0.92%. The ex-dividend date of this dividend is Thursday, October 27th. This is a positive change from Dechra Pharmaceuticals plc's previous dividend of $5.55. The official announcement can be viewed at this link.

Where is Dechra Pharmaceuticals plc's stock going? Where will Dechra Pharmaceuticals plc's stock price be in 2017?

6 equities research analysts have issued 1-year price targets for Dechra Pharmaceuticals plc's stock. Their predictions range from GBX 1,140 to GBX 1,520. On average, they expect Dechra Pharmaceuticals plc's share price to reach GBX 1,337.43 in the next year.

When will Dechra Pharmaceuticals plc announce their earnings?

Dechra Pharmaceuticals plc is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

How do I buy Dechra Pharmaceuticals plc stock?

Shares of Dechra Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Dechra Pharmaceuticals plc stock cost?

One share of Dechra Pharmaceuticals plc stock can currently be purchased for approximately GBX 1,540.


Last Updated on 2/25/2017 by MarketBeat.com Staff